Immunoglobulin E (IgE) Allergy Blood Tests - Medical Devices Pipeline Assessment, 2019

2019-11-01
Price :
Published : Nov-2019
No. of Pages : 68
Table of Contents
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Immunoglobulin E (IgE) Allergy Blood Tests Overview 6
3 Products under Development 7
3.1 Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Stage of Development 7
3.2 Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Segment 8
3.3 Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Territory 9
3.4 Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Regulatory Path 10
3.5 Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Estimated Approval Date 11
4 Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products under Development by Companies 12
4.1 Immunoglobulin E (IgE) Allergy Blood Tests Companies - Pipeline Products by Stage of Development 12
4.2 Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Stage of Development 13
5 Immunoglobulin E (IgE) Allergy Blood Tests Companies and Product Overview 14
5.1 Abionic SA Company Overview 14
5.1.1 Abionic SA Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 Amerimmune LLC Company Overview 15
5.2.1 Amerimmune LLC Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 AXO Science SAS Company Overview 17
5.3.1 AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 17
5.4 Biovator AB (Inactive) Company Overview 18
5.4.1 Biovator AB (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 18
5.5 Children's Hospital Boston Company Overview 19
5.5.1 Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 19
5.6 China Medical Technologies Inc (Inactive) Company Overview 21
5.6.1 China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 21
5.7 Cytognos, SL Company Overview 22
5.7.1 Cytognos, SL Pipeline Products & Ongoing Clinical Trials Overview 22
5.8 EUROIMMUN US LLC Company Overview 23
5.8.1 EUROIMMUN US LLC Pipeline Products & Ongoing Clinical Trials Overview 23
5.9 Ferrer inCode SL Company Overview 25
5.9.1 Ferrer inCode SL Pipeline Products & Ongoing Clinical Trials Overview 25
5.10 HOB Biotech Group Suzhou Co Ltd Company Overview 26
5.10.1 HOB Biotech Group Suzhou Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 26
5.11 Hycor Biomedical Inc Company Overview 27
5.11.1 Hycor Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.12 Institut fur Produktqualitat GmbH Company Overview 29
5.12.1 Institut fur Produktqualitat GmbH Pipeline Products & Ongoing Clinical Trials Overview 29
5.13 IRCCS San Raffaele Hospital Company Overview 30
5.13.1 IRCCS San Raffaele Hospital Pipeline Products & Ongoing Clinical Trials Overview 30
5.14 Medical Research Council Company Overview 31
5.14.1 Medical Research Council Pipeline Products & Ongoing Clinical Trials Overview 31
5.15 Stanford University Company Overview 32
5.15.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 32
5.16 Thermo Fisher Scientific Inc Company Overview 33
5.16.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 33
5.17 University of Connecticut Health Center Company Overview 34
5.17.1 University of Connecticut Health Center Pipeline Products & Ongoing Clinical Trials Overview 34
5.18 University of Nottingham Company Overview 35
5.18.1 University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 35
5.19 University of Queensland Company Overview 36
5.19.1 University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 36
5.20 VEGA Ltd Company Overview 37
5.20.1 VEGA Ltd Pipeline Products & Ongoing Clinical Trials Overview 37
6 Immunoglobulin E (IgE) Allergy Blood Tests - Recent Developments 38
6.1 Sep 24, 2019: Theradiag announces improved results for H1 2019 38
6.2 Sep 05, 2019: Thermo Fisher Scientific elects New Director to Board 40
6.3 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership 41
6.4 Jul 29, 2019: Siemens Healthineers continues to drive growth forward 41
6.5 Jul 29, 2019: Changes in the Managing Board of Siemens Healthineers 43
6.6 Jul 29, 2019: OBN announce Thermo Fisher Scientific as a new Corporate Sponsor 43
6.7 Jul 24, 2019: Thermo Fisher Scientific reports second quarter 2019 results 44
6.8 Jul 18, 2019: Theradiag announces first-half revenue up 9% 46
6.9 Jul 01, 2019: Arrayit approved for Electronic Medicare Reimbursement from the Centers for Medicare and Medicaid Services 47
6.10 May 17, 2019: SenzaGen receives new order of SEK 0.5 m from a recurring customer 47
6.11 May 02, 2019: Siemens Healthineers posts strong revenue and profit growth in the second quarter 48
6.12 May 02, 2019: New method to analyze blood shows immune cell rare; likely not involved in food allergy 49
6.13 Apr 24, 2019: Thermo Fisher Scientific announces first quarter 2019 results 50
6.14 Apr 04, 2019: Theradiag and HOB Biotech settle their legal dispute 51
6.15 Mar 27, 2019: Theradiag reports its 2018 full-year results 52
6.16 Feb 25, 2019: Thermo Fisher Scientific launches new dosimetry monitoring service 53
6.17 Feb 20, 2019: Theradiag reports annual revenues for 2018 and its year-end cash position 54
6.18 Feb 11, 2019: Siemens Healthineers to invest EUR 350 million in new Campus Forchheim 54
6.19 Jan 30, 2019: Thermo Fisher Scientific reports fourth quarter and full year 2018 results 55
6.20 Jan 28, 2019: Arrayit allergy testing services endorsed by leading Pediatrics Medical Group 58
6.21 Dec 11, 2018: TheraDiag names Bertrand de Castelnau as Chief Executive Officer 58
6.22 Dec 04, 2018: 10 Billion Lab Tests and Growing: Siemens Healthineers Mass. Manufacturing Expansion Largely Completed 59
6.23 Dec 04, 2018: 10 billion lab tests and growing: Siemens Healthineers mass. manufacturing expansion largely completed 60
6.24 Nov 19, 2018: Arrayit announces allergy testing agreement with Sutter Health 61
6.25 Nov 07, 2018: Thermo Fisher Scientific names Jim Mullen to its board of directors 61
6.26 Nov 05, 2018: Siemens Healthineers with strong finish in fourth quarter, full year targets for fiscal 2018 achieved 62
6.27 Oct 31, 2018: Appointment of Pierre Morgon as chairman of the board of directors of Theradiag 63
7 Appendix 65
7.1 Methodology 65
7.2 About GlobalData 68
7.3 Contact Us 68
7.4 Disclaimer 68

List of Tables
Table 1: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Stage of Development 7
Table 2: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Segment 8
Table 3: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Territory 9
Table 4: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Regulatory Path 10
Table 5: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Estimated Approval Date 11
Table 6: Immunoglobulin E (IgE) Allergy Blood Tests Companies - Pipeline Products by Stage of Development 12
Table 7: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Stage of Development 13
Table 8: Abionic SA Pipeline Products & Ongoing Clinical Trials Overview 14
Table 11: Amerimmune LLC Pipeline Products & Ongoing Clinical Trials Overview 15
Table 16: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 17
Table 19: Biovator AB (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 18
Table 22: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 19
Table 25: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 21
Table 28: Cytognos, SL Pipeline Products & Ongoing Clinical Trials Overview 22
Table 31: EUROIMMUN US LLC Pipeline Products & Ongoing Clinical Trials Overview 23
Table 36: Ferrer inCode SL Pipeline Products & Ongoing Clinical Trials Overview 25
Table 39: HOB Biotech Group Suzhou Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 26
Table 42: Hycor Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 27
Table 47: Institut fur Produktqualitat GmbH Pipeline Products & Ongoing Clinical Trials Overview 29
Table 50: IRCCS San Raffaele Hospital Pipeline Products & Ongoing Clinical Trials Overview 30
Table 53: Medical Research Council Pipeline Products & Ongoing Clinical Trials Overview 31
Table 56: Stanford University Pipeline Products & Ongoing Clinical Trials Overview 32
Table 59: Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 62: University of Connecticut Health Center Pipeline Products & Ongoing Clinical Trials Overview 34
Table 65: University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 35
Table 68: University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 36
Table 71: VEGA Ltd Pipeline Products & Ongoing Clinical Trials Overview 37
Table 74: Glossary 67

List of Figures
Figure 1: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Stage of Development 7
Figure 2: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Segment 8
Figure 3: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Territory 9
Figure 4: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Regulatory Path 10
Figure 5: Immunoglobulin E (IgE) Allergy Blood Tests - Pipeline Products by Estimated Approval Date 11
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData